Evaluation of tumor infiltrating lymphocytes using multiplex immunofluorescence staining of patient tumor biopsies showed a strong increase in CD8+ T‐cell densities throughout treatment, suggesting an immune response with ASP‐1929 photoimmunotherapy plus pembrolizumab. This evidence concerns the gene CD8A and neoplasm.